Maky Zanganeh, Director at Pulse Biosciences, Inc. (PLSE), bought 37,550 shares at $15.02 ($515K) on 2017-09-18, disclosed to the SEC on 2017-09-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.23 | 13,000 | $159K | 30.9% |
| 2 | $13.55 | 9,000 | $122K | 23.7% |
| 3 | $15.02 | 7,775 | $117K | 22.7% |
| 4 | $15.02 | 7,775 | $117K | 22.7% |
| Total | $13.70 avg | 37,550 | $515K | 100% |
| Filing → |
| PLSE | BUY | 2020-06-25 | $13K | — | Filing → |
| PLSE | BUY | 2020-06-19 | $111K | — | Filing → |
| PLSE | BUY | 2018-03-28 | $190K | — | Filing → |